The Latest
-
The MedTech Conference 2026
Medtech execs share secrets to building resilient supply chains
At AdvaMed’s The MedTech Conference, company executives said they’re bracing for disruption by investing in inventory, scenario planning and their relationships with chip suppliers.
-
Medtronic wins CE mark for Vitalis portfolio of cardiac pacemakers
The CE mark clears Medtronic to sell conduction system pacing therapy devices in Europe.
-
5 doctors weigh in on the promise, limitations of Grail’s multicancer test
As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer experts what encourages and concerns them most about Galleri.
-
Top medtech conferences in 2027
From AdvaMed’s meeting in San Francisco to a robotics conference in Rome, next year’s calendar is already filled with medtech events to attend.
-
FDA clears Sequel’s insulin delivery system in Type 2 diabetes
With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.
-
Edwards recall of Sapien mitral delivery systems tied to 1 death
Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three reports of balloons bursting when inflated during the procedure.
-
MiniMed completes separation from Medtronic
Medtronic exchanged all of its remaining shares of the diabetes technology spinoff.
-
AMA releases governance framework for agentic AI in healthcare
Industry groups have worked to release guidance on artificial intelligence-backed agents in the absence of federal regulation.
-
EndoQuest Robotics hires chief commercial officer
Jared Eben joins EndoQuest ahead of the anticipated launch of its flexible robotic surgery system.
-
Labcorp to buy BioReference assets for up to $872M
Labcorp will pick up specialty testing in women’s health as well as a blood test that assesses the likelihood of finding aggressive prostate cancer before a biopsy decision.
-
Zimmer and Think Surgical pen multi-year extension to robotic surgery deal
Zimmer distributes an exclusive version of Think’s wireless handheld miniature robotic system that works with its Persona knee system.
-
NEJM study supports CGM use for people with diabetes who don’t take insulin
The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare coverage of the devices for people with Type 2 diabetes.
-
Agilent to buy Proscia for $240M
The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.
-
Siemens Healthineers to stop selling general ultrasound systems
In a strategy shift, the company will invest in its procedural ultrasound business, supporting cardiovascular surgeries
-
J&J’s medtech business slows again in Q3
For the second straight quarter, the cardiovascular unit experienced slower sales growth due to ongoing struggles in the Abiomed business.
-
Orthofix pays former executives $24M in damages
The payments were made after a California arbitrator found private text messages between Orthofix executives couldn’t be considered cause for firing.
-
Steris inks $2.1B Xodus buyout to expand consumables portfolio
The takeover adds high-growth, high-margin products to Steris’ portfolio, analysts said.
-
Stryker enters soft tissue robotics with $400M investment in CMR Surgical
Stryker, which has been looking to get into the soft tissue robotics market for years, is now positioned to compete with new entrants Johnson & Johnson and Medtronic.
-
Ascensia leads $36M funding round for glucose sensor startup
Ascensia also struck an exclusive sales agreement with Sava, which is making a wearable to continuously monitor glucose and other biomarkers.
-
Philips updates instructions for ultrasound system linked to 4 deaths
A software issue can delay use of the Lumify diagnostic ultrasound system in environments without access to Wi-Fi or cellular signal.
-
Henry Schein appoints Emmanuel Caprais as CFO
The CFO transition is part of a recent wave of leadership changes at Henry Schein, including a new CEO.
-
MMI raises $125M to scale up in robotic microsurgery
The Symani surgical robot maker said the financing will help broaden adoption of the system in the U.S. and global markets and support a clinical trial for Alzheimer’s disease.
-
Medtech lobby seeks broader device eligibility for CMS’ proposed RAPID pathway
AdvaMed called for more breakthrough devices, including diagnostics, to be eligible for the pathway, and for set timelines for national coverage determinations.
-
Healthcare organizations are underprepared for quantum computing threats
Once scientists are able to develop practical quantum computers, the technology could quickly break the encryption methods protecting patient data. Experts say healthcare leaders should start preparing for that reality today.
-
Boston Scientific names Joseph Fitzgerald as chief operating officer
Fitzgerald will oversee three newly established reportable segments as Boston Scientific works to bounce back from guidance cuts.